DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice No. 09/2025-26, dated July 22, 2025.

As per the latest trade notice, the revised deadline for submission of applications for obtaining Export Authorisation has been extended to July 31, 2025. This extension follows the earlier communication under Trade Notice No. 06/2025-26 issued on June 18, 2025, which had originally set the deadline.

The notice stated that “In continuation to the earlier Trade Notice No. 06/2025-26 dated June 18, 2025, the last date for submission of application for Export Authorisation for Pharma Grade Sugar, has been extended up to July 31, 2025. All other contents of the Trade Notice remains unchanged.”

Comprehensive Guide of Law and Procedure for Filing of Income Tax Appeals, Click Here

According to the directorate, all other terms and conditions mentioned in the earlier notice are still in effect. With the high standards and sensitive nature of exporting pharmaceutical-grade sugar, the delay is meant to provide exporters more time to finish the required paperwork and regulatory compliance.

This announcement has been circulated to all Regional Authorities of DGFT, Customs Commissionerates, and members of the trade community. For any further clarification, stakeholders have been advised to contact the DGFT.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices